| Size | Price | Stock |
|---|---|---|
| 100 mg | Get quote | |
| 250 mg | Get quote | |
| 500 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-119490 |
| M.Wt: | 417.50 |
| Formula: | C24H27N5O2 |
| Purity: | >98 % |
| Solubility: | 10 mM in DMSO |
UMB-136 is a bromodomain inhibitor. UMB-136 is a promising latency-reversing agent (LRA) for HIV-1 eradication. UMB-136 reactivates HIV-1 in multiple cell models. UMB-136 enhances HIV-1 transcription and increases viral production through the release of P-TEFb[1].
In Vitro:UMB-136 (5 μM; 24 h) significantly induces HIV-1 reactivation[1].
UMB-136 (2.5 μM; 24 h) enhances HIV-1 transcription and viral production by releasing P-TEFb[1].
UMB-136 (2.5 or 5 μM) reverses HIV-1 latency in multiple cell models (THP89GFP, J-Lat full-length (dEnv) clones, primary CD4+ T cell) of HIV-1 latency[1].
UMB-136 (2.5 μM) synergizes with other LRAs (Prostratin HY-107421 or SAHA) to reverse HIV-1 latency in J-Lat cell lines[1].
Combined treatment with UMB-136 (2.5 μM) and PKC activators reverses HIV-1 latency in patient-derived resting CD4+ T cells[1].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.